Cytokinetics stock forecast
WebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% compared with the industry’s decline of 4.7%. WebStock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Cytokinetics stock forecast
Did you know?
WebMar 3, 2024 · Shareholders in Cytokinetics, Incorporated (NASDAQ:CYTK) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts.The analysts have sharply ... WebApr 6, 2024 · The stock price has decreased by -13.64% in the last 52 weeks. The beta is 0.85, so Cytokinetics's price volatility has been lower than the market average. Beta (1Y)
WebMar 7, 2024 · Cytokinetics, Incorporated's earnings is forecasted to decline at 23.5% and its revenue is expected to decline at 46.6%. Cytokinetics, Incorporated has a predicted … WebCytokinetics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Cytokinetics, Inc. 's performance made by these …
WebJan 10, 2024 · The average Cytokinetics stock forecast of $55.44 implies 57.7% upside potential from current levels.Bloggers Weigh InTipRanks data shows that financial blogger opinions are 100% Bullish on CYTK ... Web1 day ago · See the latest Cytokinetics Inc stock price (NASDAQ:CYTK), related news, valuation, dividends and more to help you make your investing decisions.
WebFeb 28, 2024 · Cytokinetics Stock Up 0.4 %. Shares of CYTK opened at $42.98 on Tuesday. Cytokinetics, Incorporated has a 52 week low of $33.10 and a 52 week high of $55.80. The firm has a market cap of $4.07 billion, a P/E ratio of -13.60 and a beta of 0.90. The firm's 50-day simple moving average is $43.66 and its 200 day simple moving …
WebDane Leone. Truist. Srikripa Devarakonda, Ph.D. UBS. Ashwani Verma. Cytokinetics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Cytokinetics, Inc. 's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cytokinetics, Inc ... scheararWebApr 6, 2024 · Cytokinetics last issued its earnings data on March 1st, 2024. The biopharmaceutical company reported ($1.45) EPS for the quarter, missing the consensus estimate of ($1.22) by $0.23. The firm had revenue of $1.96 million for the quarter, compared to analyst estimates of $7.10 million. Its revenue was down 96.5% on a year … sche ap eamcetWebFind the latest Cytokinetics, Incorporated CYTK analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range … russell 2000 index membership listWebApr 10, 2024 · Virtual Stock Exchange; Video. MarketWatch 25 Years; SectorWatch; ... Spinal Muscular Atrophy Medicine Market Size And Forecast. ... Roche acquired Cytokinetics, Inc.'s SMA program, which is a ... russell 2000 futures ticker symbolWebApr 10, 2024 · Summary of all time highs, changes and price drops for Cytokinetics; Historical stock prices; Current Share Price: US$34.99: 52 Week High: US$55.80: 52 … russell 2000 industry sectorsWebSOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock … russell 2000 index inceptionWebMar 20, 2024 · Cytokinetics Stock (NASDAQ:CYTK), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. scheap shelf wayfair